Zacks Investment Management Iradimed Corp Transaction History
Zacks Investment Management
- $10.5 Billion
- Q4 2024
A detailed history of Zacks Investment Management transactions in Iradimed Corp stock. As of the latest transaction made, Zacks Investment Management holds 4,500 shares of IRMD stock, worth $253,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,500Holding current value
$253,080% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IRMD
# of Institutions
165Shares Held
6.78MCall Options Held
600Put Options Held
900-
Nine Ten Capital Management LLC Evanston, IL906KShares$50.9 Million14.22% of portfolio
-
Black Rock Inc. New York, NY818KShares$46 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA537KShares$30.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny513KShares$28.9 Million0.04% of portfolio
-
Copeland Capital Management, LLC476KShares$26.7 Million0.5% of portfolio
About IRADIMED CORP
- Ticker IRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 12,565,100
- Market Cap $707M
- Description
- IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...